
    
      Treatment scheme

      :Gemcitabine 1000 mg/m2/d IV D1 as a 10mg/m2/min Oxaliplatin 85 mg/m2/d IV D2 as a 2 hours
      infusion

      Each cycle is repeated every 2 weeks.

      Repeated cycles of treatment will be given for this study unless there is confirmed disease
      progression or unacceptable toxicity. Subjects will be treated for at least 4 cycles unless
      there is documented disease progression, unacceptable adverse events or withdrawal of
      consent.
    
  